People

The People

Grade: B. Founder Changlin Liang owns 25% economically but controls roughly 69% of the vote through Class B super-shares, and he still chairs the nominating committee and sits on the compensation committee that approves his own pay. Offsetting that, the new CEO is a 17-year industry finance veteran, comp is modest, related-party history is clean, and the pending US$717M+ Meituan sale is being teed up almost entirely for buybacks and dividends — a textbook capital-return signal if it closes.

1. The People Running This Company

The bench is thin but credentialed: a founder still in full control, a finance-trained operator just elevated to CEO, and a small inner circle that has worked together for the better part of a decade. Five people effectively run the company.

The capability question for Wang is easy: he was the architect of the financial discipline that drove 14 straight quarters of non-GAAP profit, and he has CFO seats at Lianhua (HKEX-listed) and head-of-finance at Hema Fresh on his résumé — both are direct analogues of Dingdong's grocery model. The harder question is whether a finance-trained CEO can also run merchandising and consumer-product strategy. With Liang still chairing the board and the nomination committee, in practice Wang inherits execution but Liang keeps strategic direction.

Yi Ding and Zhijian Xu provide the operating depth — Ding has been inside the company since 2015 (pre-renaming, when it was still part of Liang's MaMaBang lineage), and Xu's 24 years at Charoen Pokphand brought industrial-scale fresh-supply-chain experience that a software-led founder would not have on his own. There is no obvious bench beneath them.

2. What They Get Paid

Compensation is the easiest part of this dossier: it is small and largely in equity, with no pension or retirement accruals. For an NYSE-listed company doing roughly ¥24 billion of GMV, the cash bill is conspicuously low.

Wang's options were granted at a zero exercise price — that is unusual and rich (effectively a free equity award subject to vesting), but the share count is small. The bulk of equity value lives in Yi Ding's stack, which makes sense given his 11-year tenure. Founder Liang has been granted no options at all; he does not need them, given his 25% stake. Non-executive directors as a group received about US$150,000 (≈¥1.04M) in total — modest enough that it raises no independence concern by itself but offers little incentive to push back.

For context, ¥22.8M of aggregate executive cash compares to FY2025 net income of ¥221.7M — roughly 10% of profit, which is low for an NYSE-listed operator. Pay is earned relative to size; if anything it is under-paid in cash terms, with most of the upside in options that are deep in the money only because the share price has collapsed 89% from the 2021 IPO close.

3. Are They Aligned?

This is the section where the story sharpens. Economic alignment is high; voting alignment is one-sided; and the single biggest alignment signal of the past five years — using nearly all of a US$717M+ disposal for buybacks/dividends — only counts if the Meituan deal actually closes.

Ownership and control

Liang's 54.5M Class B shares carry 10 votes each (≈545M votes) versus 300M Class A shares with 1 vote each. He alone controls roughly 68.6% of the vote on every shareholder resolution, including any vote to approve the Meituan transaction itself. Outside shareholders own almost three-quarters of the economics but cannot, in practice, outvote him on anything.

Insider activity

Dilution / option grants / share count

Outstanding equity awards total roughly 35.4 million shares (4.55M to D&O, 30.8M to other employees), against 354.3 million ordinaries outstanding — a ~10% potential overhang. The 2025 Plan adds capacity for another 10.6 million shares. The weighted-average strike for other-employee options is US$0.93/share, which the ADS price (~US$3.83 = US$2.55 × 1.5 shares-per-ADS) sits well above. Dilution risk is modest, not alarming — and is about to be more than offset by the announced buyback.

Capital allocation and the Meituan transaction

On 2026-02-05 Dingdong signed a definitive agreement to sell 100% of Dingdong Fresh Holding Limited (the entire mainland China retail operation) to Two Hearts Investments Limited — a Meituan affiliate — for US$717M up front plus up to US$280M in earn-outs (≈¥4.94B + ≈¥1.93B). On 2026-02-25 the company announced it intends to use "a substantial majority" of those cash proceeds for share repurchases and/or dividends. For a company with a current market capitalization around US$467M (≈¥3.25B), this is potentially a return of cash multiples greater than today's market cap — provided the deal closes (antitrust clearance, divestiture-plan conditions, and Investor closing conditions remain outstanding).

Related-party behavior

Item 7.B of the FY2025 20-F discloses essentially no material related-party transactions beyond employment agreements, indemnification agreements, and the standard ESOP. The Meituan share-purchase agreement explicitly carves out dividends, capital returns, debt repayments and waiver of claims to "Outside Entities, the Founder, or their Affiliates" during the transition period — i.e., the buyer is forcing arm's-length conduct. Audit-committee approval of related-party transactions is required by charter. Concerns: minor — the only structural risk is that Liang is sole administrator of the ESOP and has sole voting control of EatBetter Holding Limited (6.8% of shares).

Skin-in-the-game score

Liang's 25.2% economic stake at ~US$150M of value is material to him by any standard; he has never sold a share in disclosed records; option grants to executives are real and broad-based; the buyback signal is among the strongest a small-cap can deliver. The score is held back from 9–10 by the dual-class structure (which decouples voting from economics) and the small but real pre-promotion sale by the incoming CEO.

4. Board Quality

Six directors, two truly independent, and a founder who chairs the nomination/governance committee and sits on the compensation committee. By NYSE Standards this board would not pass an independent-majority test; Dingdong claims an FPI exemption and meets the minimum (audit committee fully independent), but the governance posture is closer to formal independence than real independence.

Real strengths. Philip Leung is unusually well-credentialed for a small-cap audit chair — 30 years at EY, former Greater China managing partner of EY listing services, and now SAIF Partners-veteran independent at China World Trade Center, Dongfeng Motor, Zhejiang E-Commerce Bank, and the Shanghai Chemical Industry Park gas JV. Ed Chan brings exactly the right operating CV — former Walmart China CEO (2006–2011), former Yum China board, current Treasury Wine Estates non-executive — for a grocery business. The audit committee is 100% independent, and the long-tenured Ernst & Young Hua Ming has signed unqualified opinions including the FY2025 ICFR effectiveness opinion.

Real weaknesses. Only two of six directors are independent (33%). Liang chairs the nominating and corporate governance committee — meaning he effectively chooses his own oversight. Liang also sits on the compensation committee alongside the two independents (with Chan as chair), which means the founder is in the room when his own affiliated managers' option grants are sized. There is no female representation. Two of three committees are not independent-majority. There is no separately-designated lead independent director.

5. The Verdict

The strongest positives

1. Massive pending capital return. Up to US$997M (≈¥6.9B) of disposal proceeds — substantial majority earmarked for buybacks and dividends — against a US$467M market cap.
2. Founder economic alignment. 25.2% stake worth roughly US$150M, no record of founder selling, modest cash compensation, options held disproportionately by long-tenured operators rather than the founder himself.
3. Clean related-party history. The FY2025 20-F discloses no material RPT beyond employment / indemnification agreements; the Meituan SPA explicitly limits affiliate transactions during the transition period.
4. Quality of independent directors. Audit chair Leung is a top-tier ex-EY partner; Chan ran Walmart China — both bring genuine challenge capability where they sit.

The real concerns

1. Dual-class voting control. Liang controls ~69% of votes on 25% of economics; outside shareholders cannot outvote him on any matter including the Meituan transaction.
2. Board independence is formal, not real. 2 of 6 independent, founder chairs nom-gov, founder sits on comp, no lead independent director.
3. Single-administrator ESOP. Liang sole administrator of the share incentive plan and sole voting controller of EatBetter Holding (6.8% block).
4. Insider information opacity. FPI status means no Form 4s; the only insider trades visible (Wang's US$536K sale eleven months before promotion; Xu's US$359K sale) cannot be assumed to be exhaustive.

The one thing that would move the grade

The Meituan transaction is the single largest governance test in the company's history. If the buyback executes in the disclosed magnitude and is completed within 12 months of closing, the grade moves to B+/A- — alignment will have been proven with cash, not promises. If the deal slips, fails antitrust clearance, or proceeds are redirected to anything other than buybacks/dividends, the grade moves to C — the dual-class concentration and committee composition will look like control rather than stewardship.